Skip to ContentSkip to Navigation
How to find us drs. G. Piersma-Wichers


Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study

More precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot study

Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN

Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN)

Directe orale antistollingsmiddelen ook in Nederland een goede keus

Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation

Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients

Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists

Impact of vitamin k antagonists (VKA) on quality of life (QOL) in a prospective cohort of 807 atrial fibrillation (AF) patients

Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients

Read more